Insights
Judge Appoints Elite Legal Team to Lead Depo-Provera MDL
Justice for Brain Tumor Victims In a decisive step toward justice for women suffering from brain tumors allegedly linked to Depo-Provera injections, Judge M. Casey Rodgers has issued Pretrial Order No. 18 on March 16, 2025, establishing a formidable leadership...
Depo-Provera Lawsuit: A New Frontier in Mass Tort Litigation
As the legal landscape shifts in response to growing concerns over the birth control injection Depo-Provera, law firms are seeing a rise in claims from injured patients. Manufactured by Pfizer, Depo-Provera has been linked to severe side effects such as osteoporosis...
Mastering Mass Torts: True Costs, Feedback Loops, and Vendor Relationships
Mass tort litigation is one of the most challenging and high-stakes areas of legal practice. It involves coordinating thousands of plaintiffs and navigating the complexities of case acquisition, case development, and settlement negotiations. Devin Downey, co-founder...
AI is Taking Over Some Call Centers—But Here’s Why Human Intake Will Keep Crushing It in Mass Tort and Personal Injury
There’s no denying it: artificial intelligence is shaking up industries left and right, and legal intake is no exception. With podcasts like All-In declaring that AI will wipe out call centers in the next few years, it’s easy to get swept up in the idea that...
New Mass Tort Alert: In re: Angiodynamics, Inc. Port Catheter Product Liability Litigation
The mass tort world has just gained a significant new case. Following the September 26th U.S. Judicial Panel on Multidistrict Litigation (JPML) hearing, yesterday’s order officially confirmed the creation of a new mass tort: In re: Angiodynamics, Inc. Port Catheter...
The Story Behind the Blue Sky Legal Name
When I first set foot on the Blue Sky Trail in Winter Park, Colorado, I had no idea it would become the inspiration behind Blue Sky Legal. Like a lot of people, I found myself in an unfamiliar situation when the COVID pandemic hit. The world had slowed down, and I...